Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0000917520-08-000047
Filing Date
2008-08-21
Accepted
2008-08-21 17:38:24
Documents
1
Period of Report
2008-08-19

Document Format Files

Seq Description Document Type Size
1 av081908form4_ex.html 4  
1 av081908form4_ex.xml 4 3557
  Complete submission text file 0000917520-08-000047.txt   5629
Mailing Address 311 C ENTERPRISE DRIVE PLAINSBORO NJ 08536
Business Address 311 C ENTERPRISE DRIVE PLAINSBORO NJ 08536 6092750500
INTEGRA LIFESCIENCES HOLDINGS CORP (Issuer) CIK: 0000917520 (see all company filings)

EIN.: 510317849 | State of Incorp.: DE | Fiscal Year End: 1206
SIC: 3826 Laboratory Analytical Instruments

Mailing Address C/O BARRIER THERAPEUTICS, INC. 600 COLLEGE ROAD EAST, SUITE 3200 PRINCETON NJ 08540
Business Address C/O PENNWEST PHARMACEUTICALS CO. 39 OLD RIDGEBURY ROAD, STE. 11 DANBURY CT 06810-5120 609 945-1200
VANLENT ANNE (Reporting) CIK: 0001229243 (see all company filings)

Type: 4 | Act: 34 | File No.: 000-26224 | Film No.: 081032947